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Effects of Korean ginseng berry extract (GB0710) on
penile erection: evidence from in vitro and in vivo studies
Kang Su Cho1, Chan Woong Park2, Chun-Ki Kim3, Hee Young Jeon2, Wan Gi Kim2, Sang Jun Lee2,
Young-Myeong Kim3, Joo Yong Lee1 and Young Deuk Choi1,4
Several reports have promoted the root-derived Korean red ginseng (KRG; Panax ginseng) as alternative treatment for erectile
dysfunction (ED), and ginsenosides are known to be the principal active ingredients of ginseng. Recent studies showed that ginseng
berries producemore ginsenosides than KRG; thus, we investigated the ability of the Korean ginseng berry extract GB0710 to relax the
penile corpus cavernosum smoothmuscle (CCSM) in this study. As a comparative control, the results were compared to those obtained
using KRG. In addition, possible mechanisms of action for GB0710 were investigated. While KRG and GB0710 both displayed
dose-dependent relaxation effects on precontracted rabbit CCSM in vitro, GB0710 was shown to be more potent than KRG. The
GB0710-induced relaxation could be partially reduced by removing the endothelium. In addition, pre-treatment with several nitric
oxide (NO) inhibitors significantly inhibited the relaxation of muscle strips. Furthermore, administration of GB0710 increased
intracavernosal pressure (ICP) in a rat in vivo model in both a dose- and duration-dependent manner. Intracellular NO production in
human microvascular endothelial cells could be induced by GB0710 and inhibited by NG-monomethyl-L-arginine. In conclusion,
GB0710 had a greater relaxation effect on rabbit CCSM than did KRG extract, and increased ICP in a rat model in both a dose- and a
duration-dependent manner. This relaxing effect might be mediated by NO production.
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INTRODUCTION
Erectile dysfunction (ED) is defined as the inability to attain or main-
tain penile erection sufficient for satisfactory sexual intercourse. ED is
a common condition in middle-aged men that has serious adverse
effects on quality of life. It has been reported that approximately
50% of men aged 40–80 years suffer from ED to some degree.1
One of the etiological causes of ED is the reduced bioavailability of
nitric oxide (NO). This causes insufficient relaxation of smooth mus-
cle in the penile corpus cavernosum, leading to a subsequently insuf-
ficient inflow of blood. Several extensive studies have investigated the
positive effects of ginseng on ED, thereby implicating the NO pathway
as the mechanism of action.2,3 Among these, various reports have
promoted the root-derived Korean red gingseng (KRG; Panax gin-
seng) as alternative treatment for ED, citing the stimulatory effect of
KRG on the corpus cavernosum smooth muscle (CCSM) of the
penis.4–6 The principal active ingredients of ginseng are ginsenosides
(also called ginseng saponins), which are amphiphilic molecules com-
prised of an aglycon backbone (a hydrophobic four-ring steroid-like
structure) linked to hydrophilic carbohydrate side chains that consist
of monomers, dimers and tetramers.5,7
Ginsenoside is widely and variably distributed thoughout the gin-
seng plant.8 Kim et al.9 investigated the ginsenoside content of Korean
ginseng, indicating ginseng berries (GB) and ginseng roots (which
comprise KRG) as themost abundant parts. Specifically, they reported
that GB produce more total ginsenosides, with a 4–6 times higher of
total ginsenoside content than KRG. Further, when researching the
well-established antiglycemic effects of KRG,10 Dey et al.11 suggested
that GB exhibit more potent antihyperglycemic activity than the KRG,
and that GB are unique in their anti-obesity effects in ob/ob mice. For
these reasons, we hypothesized that GB extract may have a stronger
relaxation effect on CCSM than KRG extract. To confirm this, we
investigated the ability of GB to relax CCSM, using KRG as a com-
parison. In addition, we evaluated the possible mechanisms of the
action of GB extract.
MATERIALS AND METHODS
Animal care and all experimental procedures were carried out with the
approval of the Institutional Animal Care and Use Committee of
Yonsei University Health System (Seoul, Korea). The in vitro experi-
ments used male New Zealand white rabbits (4–6 months old, 2.5–
3.5 kg) and the in vivo experiments used male Sprague Dawley rats
(200–250 g).
Preparation of GB extract (GB0710)
Raw GB (Panax ginseng, CA, Meyer) were harvested in July from
plants cultivated in the Chungbuk province in Korea, and the seeds
1Department of Urology, Severance Hospital, Urological Science Institute, Yonsei University College of Medicine, Seoul 120-752, Korea; 2R&D Center, Amorepacific Corporation,
Yongin, Gyeonggi-do 446-729, Korea; 3Vascular System Research Center and Department of Molecular and Cellular Biochemistry, School of Medicine, Kangwon National
University, Chunchon 200-701, Korea and 4Clinical Trial Center for Medical Devices, Yonsei University College of Medicine, Seoul 120-752, Korea
Correspondence: Dr YD Choi (youngd74@yuhs.ac)
Received: 5 January 2013; Revised: 15 February 2013; Accepted: 27 March 2013; Published online: 27 May 2013
Asian Journal of Andrology (2013) 15, 503–507
 2013 AJA, SIMM & SJTU. All rights reserved 1008-682X/13 $32.00
www.nature.com/aja
were separated and removed. The flesh, juice, and skin of the GB were
dried in hot air. The dried GB were first refluxed with 70% ethanol for
10 h, after which the extract was filtered and concentrated under
reduced pressure at 45 uC, thus obtaining the GB extract (GB0710).
Preparation of red ginseng extract (ginseng root)
Red ginseng (Panax ginseng, CA, Meyer), cultivated and manufac-
tured in Chungbuk province in Korea was added to ethanol and
extracted under reflux. The extract was filtered and concentrated
under reduced pressure. The concentrations of seven major ginseno-
sides in GB0710 and KRG extract were analyzed by high-performance
liquid chromatography. The results are shown in Figure 1.
In vitro experiments
Forty-two rabbits were used for the in vitro experiments, and they were
anesthetized with phenobarbital sodium (50 mg kg21). The penis was
surgically removed en bloc, with care taken to keep the tunica albugi-
nea intact. The corpus cavernosum was carefully dissected from the
surrounding tunica albuginea. Two strips of corpus cavernosum tis-
sue, measuring approximately 23236 mm, were obtained from each
rabbit and mounted in 10 ml organ chambers containing Tyrode
solution (pH 7.4) at 37uC, equilibrated with 95% oxygen and 5%
CO2. The strips were suspended with silk ties to a force–displacement
transducer (TSD 105; Biopac Systems, Santa Barbara, CA, USA).
Changes in isometric tension were measured using MP100WS
(Biopac Systems). The following protocol was used: the prepared
strips were stimulated with 531026 mol l21 phenylephrine (Phe;
Sigma-Aldrich, St Louis, MO, USA) every 15 min with stepwise
stretching (0.5 g tension/stretch). When the difference of the ampli-
tude of contraction was within 10% of the previous contraction, that
tension was considered optimal for isometric contraction.
GB0710 and KRG extract were added to the resting equilibrated
muscle strips for the evaluation of their relaxation effects under basal
conditions. After the muscle strips were stabilized in contraction with
Phe (531026 mol l21), the effects of various concentrations (0, 10, 20,
50, 100 and 150mgml21) of GB0710 and KRG extract were evaluated.
To evaluate the relaxation mechanism, the effects of GB0710 on pre-
contracted strips were also evaluated for strips incubated with either a
nitric oxide synthesis (NOS) inhibitor, NG-nitro-L-arginine (L-NNA;
331024 mol l21), a guanylate cyclase inhibitor, methylene blue
(1024 mol l21) or 1H-[1,2,4] oxadiazolo-[4, 3-a] quinoxalin-1-one
(ODQ; 531026 mol l21), or the NO scavenger pyrogallol (1024 mol l21).
L-NNA, methylene blue, ODQ and pyrogallol were purchased from
Sigma-Aldrich. Disruption of the endothelium was achieved by rubbing
the CCSM strip between the thumb and index finger for approximately
20 s. After rinsing in chilled Tyrode solution, the strip was gently rolled
across a dry paper towel to generate shear forces across the endothelial
surface of the lacunar space. Removal of the endothelium was confirmed
by the absence of the relaxation response to acetyl choline (1025 mol l21)
or relaxation within 10% of the range in the control state. The effect of the
inhibitors was studied by pre-incubation with each inhibitor for 20 min,
after which contraction was induced by Phe and the relaxation profiles of
GB0710 vs KRG extract were observed. Each strip was used in up to four
separate rounds of testing, washing them three times with Tyrode solution
and equilibrating for 30 min between rounds.
In vivo experiments
A total of 160 rats were used. They were divided into four time groups
(1, 2, 3 and 4 weeks; n540 in each group), and then each time group
was subdivided into five dosage groups according to the dosage of
GB0710 (0, 20, 40, 100 and 150 mg kg21 day21; n58 in each sub-
group). For the administration of GB0710, GB0710 was mixed with
physiologic saline and administered daily by mouth, and control
group subjects were given equal doses of physiologic saline.
Rats were anaesthetized by intraperitoneal injection of sodium pen-
tobarbital (30–50 mg kg21), and the bladder and prostate were
exposed via transperitoneal midline incision. The pelvic trunk located
at the posterolateral wall of the prostate was identified, and the caver-
nosal nerve was isolated. A platinum electrode was placed on the
cavernosal nerve and connected to an electric stimulator (STM100A;
Biopac Systems). After incising the penile skin, the corpus cavernosum
was isolated. To measure the intracavernosal pressure (ICP), a
26-gauge needle was placed into the corpus cavernosum. To simulta-
neously monitor systemic blood pressure, a 22-gauge angio-catheter
was inserted into the carotid artery and connected to a transducer and
polygraph system. The outputs for systemic blood pressure and ICP
were connected to a sequential amplifier (DA100; Biopac Systems) via
a Sorenson transpac (Abbott Critical Care System, Chicago, IL, USA).
Pressure lines and catheters were prevented from clotting by periodic
irrigation with heparinized saline. After 1–4 weeks of administering
GB0710 (0, 20, 40, 100 and 150mg kg21 day21), the maximal ICP was
continuously measured under cavernous nerve stimulation at low
voltage (voltage 2 V; frequency 12 Hz; pulse-width 1 ms; duration
1 min), as healthy animals were used in this study.12 To minimize
the influence of cavernous nerve stimulation on the blood pressure,
which would artificially raise the ICP, the data were presented as the
percentage of ICP/systolic blood pressure (SBP). After every ICP
study, the tested rats were euthanized.
Intracellular NO production in cell culture
To measure NO production in response to GB0710 administration,
human microvascular endothelial cells (HMVECs) were purchased
from Lonza Walkersville, Inc. (Walkersville, MD, USA). HMVECs
were cultured in complete microvascular endothelial cell growth me-
dium (EGM-2 MV, SingleQuots; Lonza Walkersville, Inc.), in a
humidified 5% CO2 incubator at 37uC. The cellular NO level was
measured in situ using the NO-specific fluorescent probe 4-amino-5-
methylamino-2,7-difluorofluorescein diacetate (DAF-FM/DA; Molecular
Probes, Eugene, OR, USA) according to the manufacturer’s instruc-
tions. The cells were pretreated with or without a NOS inhibitor,
Figure 1 Percentage weight of the seven ginsenosides in GB0710 and KRG
extract obtained by high-performance liquid chromatography analysis. KRG,
Korean red ginseng; Rb1, ginsenoside-Rb1 (C54H92O23); Rb2, ginsenoside-
Rb2 (C53H90O22); Rc, ginsenoside-Rc (C53H90O22); Rd, ginsenoside-Rd
(C48H82O18); Re, ginsenoside-Re (C48H82O18); Rg1, ginsenoside-Rg1
(C42H72O14); Rg2, ginsenoside-Rg2 (C42H72O13).
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NG-monomethyl-L-arginine (L-NMMA, 2 mmol l21), for 30 min, fol-
lowed by exposure to GB0710 (200 mg ml21) or KRG (200 mg ml21)
for 1 h. L-NMMA is a relatively non-selective inhibitor of all NOS iso-
forms. The cells were incubated in medium containing DAF-FM/DA
(10 mmol l21) for 1 h at 37uC, washed in phenol red-free medium, and
fluorescence images were captured from at least 10 randomly selected cells
per dish using a confocal laser microscope. The relative level of intracel-
lular NO was determined from the fluorescence of triazole, which is a
specific product of the reaction between DAF-FM and NO.
Statistics
All relaxation responses were expressed as a percentage of maximal
relaxation, based on the perpendicular vertical distance between the
Phe-induced maximal contraction point and the largest downward
deflection in the tracing for any given experiment. Inhibitory effects
on contractile responses were expressed as percentage of the contrac-
tion in the control state. Results were expressed as mean6standard
error of the mean, using a Mann–Whitney U test to evaluate the
significance of differences in the relaxation effect, ICP and the image
density between treatment and control. A Kruskal–Wallis test was
applied to determine significant differences among three or more
groups at the same concentration of treatment. SPSS for Windows
version 12.0 was used for statistical analysis. P values were two-sided,
and a P value of less than 0.05 was considered significant.
RESULTS
In vitro comparison of GB0710 with KRG extract with regard to the
relaxation of isolated rabbit CCSM
While the KRG extract caused contraction at low concentrations in
the Phe-induced precontracted CCSM, both GB0710 and KRG extract
caused relaxation of the CCSM at high concentrations (o10 mg ml21
for GB0710, ando20 mg ml21 for KRG). Hence, GB0710 showed a
more powerful relaxation effect than KRG extract. For both sub-
stances, a concentration-dependent relaxation effect was observed,
with the maximal effect at 150 mg ml21 (96.3%612.4% in GB0710,
and 72.8%611.8% in KRG) (Figure 2). The half maximal inhibitory
concentration of GB0710 was 39.3 mg ml21, and that of KRG was
111.9 mg ml21.
GB0710-induced CCSM relaxation in conjunction with the NO
pathway
These GB0710-induced relaxation was partially reduced by removing
the endothelium (P,0.05; Figure 3). In addition, pre-treatment with
any of the NO-inhibitors was able to partially inhibit the relaxation of
muscle strips (P,0.05; Figure 3).
In vivo investigation of the effect of GB0710 on rat CCSM
As reaction to the increased dosage of GB0710, the ICP/SBP (%)
increased in a dose-dependent fashion. After 4 weeks of treatment,
the ICP/BP (%) was 30.264.4, 43.964.8, 59.565.6, 70.763.1 and
73.564.0 with GB0710 treatment of 0, 20, 40, 100 and 150 mg kg21
day21, respectively. In addition, the maximal ICP/SBP (%) for each
group increased in a duration-dependent fashion (Figure 4). When
treated with a dose of 150 mg kg21 day21 GB0710, ICP/BP (%) was
47.464.5, 54.764.4, 67.864.3 and 73.564.0 after 1, 2, 3 and 4 weeks,
respectively.
Effect of GB0710 on inducing intracellular NO production in
HMVECs
GB0710 increased the intracellular production of NO in HMVECs
compared to control cells, and this increase was inhibited to control
levels by co-treatment with the NOS inhibitor L-NMMA (Figure 5).
DISCUSSION
Many folk remedies claim to improve male ED, including phytoche-
micals such as extract of Lepidium meyenii, Ferula hermonis, Ginkgo
biloba and Aspidosperma ulei, among others.13–15 A recent systematic
review of randomized clinical trials revealed that Panax ginseng
improves glucose metabolism and moderates the immune response.16
KRG is also used as a tonic to maintain physical vitality and for res-
torative purposes throughout East Asian countries, including Korea
and China. Our study demonstrates that GB0710 has a greater relaxa-
tion effect on rabbit CCSM than does KRG extract, and that it
Figure 2 (a) Effects of both GB0710 and KRG extract on the isolated rabbit corpus cavernosum smooth muscle strips submaximally precontracted by phenylephrine
(531026 mol l21). The relaxation effect showed a dose-dependent relaxation, but the relaxation effect of GB0710 was higher than KRG extract. Values are represented
as mean6standard error and expressed as percentage of the relaxation. (b) Representative graphs of GB0710 effects on the isolated rabbit corpus cavernosal smooth
muscle strip precontracted by phenylephrine (531026 mol l21). *P,0.05, the difference between treatment and control by Mann–Whitney U test; {P,0.05, the
difference between GB0710 treatment and that of KRG treatment at the same concentrations by Mann–Whitney U test. KRG, Korean red ginseng.
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increases the ICP in an in vivo rat model. We also demonstrated that
these positive effects may be due to a relaxing effect mediated by NO
production. To the best of our knowledge, this is the first study which
has shown that GB extract can enhance erectile capability.
The first phosphodieterase-5 inhibitor has been available on the
market since 1998, and several phosphodieterase-5 inhibitors have
become the first line therapy for men with ED. Although evidence-
based sexual drug treatment has increased tremendously over the past
two decades, and despite effective well-established treatment options
for ED, many patients are still dissatisfied.17 Dropout rates for current
medical therapies are high, and overall satisfaction is below expecta-
tion due to drug inefficiency and adverse events such as headache and
hot flashes. Further, while ED can generally be treated successfully
using current treatment options, it cannot be cured. For these reasons,
phytotherapy remains an important alternative treatment. A recent
systematic review provided evidence for the effectiveness of red gin-
seng in the treatment of ED from six randomized clinical trials.18
Although there were some limitations in the sample sizes and the
methodological qualities of the primary studies,18 this meta-analysis
found a significant effect of the tested herbal medicine (n5349, risk
ratio52.40, 95% CI51.65–3.51, P,0.00001, heterogeneity: t250.05,
x256.42, P50.27, I2522%). Subgroup analyses also showed beneficial
effects of red ginseng in psychogenic ED (n5135, risk ratio52.05; 95%
CI51.33–3.16, P50.001, heterogeneity: x250.08, P50.96, I250%).
As aforementioned, several researchers showed that red ginseng
might induce relaxation of the smooth muscles of the corpus carver-
nosum via the NO pathway, and ginsenosides are thought to be the
principle active constituents of red ginseng. The content and composi-
tion of ginsenosides vary in the ginseng roots, leaves and berries, and
the pharmacologically active components of ginseng remain unclear
despite several trials to identity them. Although KRG extract prepared
from the root of the plant has been most commonly used for herbal
medicine, GB can be used similarly to treat diseases and sexual dys-
function, as well as for aphrodisiac purposes.11,19 Using GB also has
economic advantages over KRG, because KRG is made from 6-year-
old ginseng plants, whereas GB can be harvested yearly. Moreover, our
analysis revealed markedly higher ginsenoside concentration in
GB0710 than in KRG as shown in Figure 1. Notably, the concentra-
tions of most ginsenosides (ginsenosides-Rb2, Rc, Rd, Re, Rg1 and
Rg2) were higher in GB0710 than in KRG extract. Further studies are
required to elucidate the exact mechanism of action of GB0710.
Ginsenosides have been shown in a rabbit model to cause a dose-
dependent relaxation of the CCSM by increasing the release of
NO.5,20,21 In a previous study, we described several candidate path-
ways involved in KRG-induced relaxation.5 One of those pathways
involves NO, a potent relaxant for peripheral vascular smooth muscle,
whose action is mediated by cyclic GMP. Acetylcholine may stimulate
the formation of an endothelium derived relaxing factor, which has
subsequently been identified as either a NO, or a chemically unstable
NO precursor. We show here that the relaxation effect of GB0710 on
CCSMwas partially reduced by various NO inhibitors. In addition, we
found that GB0710 increased intracellular NO production in cultured
HMVEC cells, which was attenuable by co-treatment with the NOS
inhibitor L-NMMA. These findings confirm that the relaxation effect
of GB0710 is mediated through the NO pathway, which is in accor-
dance with several studies by others.22,23
Alternatively, Sung et al.7 demonstrated that ginsenoside activates
large-conductance K(Ca) channels, which induce CCSM relaxation.
Figure 4 Intracavernosal pressure with cavernosal nerve stimulation after long-
term administration of GB0710. After administration of GB0710 at doses of 20,
40, 100 and 150 mg, intracavernosal pressure increased in a dose- and duration-
dependent fashion. *P,0.05, the difference between treatment and control by
Mann–Whitney U test; {P,0.05, the difference among various groups at the
same concentrations of each treatment by Kruskal–Wallis test.
Figure 5 GB0710 induced intracellular NO production in HMVECs. (a) HMVECs
were treated with GB0710 (200 mg ml21) or KRG (200mg ml21) in the presence or
absence of L-NMMA (2 mmol l21) for 30 min, followed by incubation with DAF-
FM/DA (10 mmol l21) for 1 h. Intracellular NO levels were determined by confocal
microscopy. (b) The relative levels of NO were calculated from fluorescence
intensities. *P,0.05, the difference between treatment and control by Mann–
Whitney U test. DAF-FM/DA, 4-amino-5-methylamino-2,7-difluorofluorescein
diacetate; HMVEC, human microvascular endothelial cell; KRG, Korean red gin-
seng; L-NMMA, NG-monomethyl-L-arginine; NO, nitric oxide.
Figure 3 Effects of various treatments on GB0710-induced relaxation in the
phenylephrine (531026 mol l21)-induced precontracted rabbit isolated corpus
cavernosum smooth muscle strip. The relaxation effect of GB0710 was partially
inhibited by endothelial disruption and by pretreatment with methylene blue
(1024 mol l21), pyrogallol (1024 mol l21), L-NNA (331024 mol l21), or 1H-
[1,2,4] ODQ (531026 mol l21). Values are represented as mean6standard error
and expressed as percentage of the relaxation. *P,0.05, the difference between
treatment and control by Mann–Whitney U test. L-NNA, NG-nitro-L-arginine;
ODQ, oxadiazolo-[4, 3-a] quinoxalin-1-one.
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Meanwhile, it has been suggested that the KRG-mediated protection
from ED is linked to its ability to scavenge oxygen radicals in a rat
model of non-insulin-dependent diabetes mellitus. Oxidative stress is
an important factor in vascular complications of diabetes.24 In addi-
tion, a recent study by Kim et al.25 suggested that KRG may improve
erectile function in a rat model of metabolic syndrome with erectile
dysfunction. It showed that the peak ICP and cGMP level of the
placebo-treated group was markedly decreased compared to the
KRG-treated group. We used healthy animals in this study before
introducing a pathological condition such as diabetes mellitus or
hypercholesterolemia, therefore further research using an animal
model of ED is desirable. While future clinical trials are needed to
determine the efficacy and safety of GB0710 for human use, our results
suggest that GB0710 is a viable alternative to current therapeutic
options for ED.
Cumulatively, we found that GB0710 had a greater relaxation effect
on rabbit CCSM thanKRG. Further, GB0710 increased the ICP in a rat
model in both a dose- and a duration-dependent manner. According
to our in vitro findings, GB0710 likely exerts its effect through the NO
pathway. Further studies are required to elucidate the exact mecha-
nism of action of GB0710, and its possible role in the treatment of ED.
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